140 related articles for article (PubMed ID: 31854207)
1. Effect of Early Initiation of Varenicline on Smoking Cessation in COPD Patients Admitted for Exacerbation: The Save Randomized Clinical Trial.
Le Mao R; Tromeur C; Paleiron N; Sanchez O; Gagnadoux F; Jouneau S; Magnan A; Hayem-Vannimenus C; Dansou A; Proust A; Dion A; Larhantec G; Brestec AL; Dewitte JD; Roche N; Leroyer C; Couturaud F
COPD; 2020 Feb; 17(1):7-14. PubMed ID: 31854207
[TBL] [Abstract][Full Text] [Related]
2. Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial.
Politis A; Ioannidis V; Gourgoulianis KI; Daniil Z; Hatzoglou C
Chron Respir Dis; 2018 May; 15(2):146-156. PubMed ID: 29117796
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.
Gray KM; Baker NL; McClure EA; Tomko RL; Squeglia LM; Saladin ME; Carpenter MJ
JAMA Pediatr; 2019 Dec; 173(12):1146-1153. PubMed ID: 31609433
[TBL] [Abstract][Full Text] [Related]
4. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.
Tashkin DP; Rennard S; Hays JT; Ma W; Lawrence D; Lee TC
Chest; 2011 Mar; 139(3):591-599. PubMed ID: 20864613
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV.
Ashare RL; Thompson M; Serrano K; Leone F; Metzger D; Frank I; Gross R; Hole A; Mounzer K; Collman RG; Wileyto EP; Schnoll R
Drug Alcohol Depend; 2019 Jul; 200():26-33. PubMed ID: 31082665
[TBL] [Abstract][Full Text] [Related]
6. Effect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers: The Kick It at Swope IV Randomized Clinical Trial.
Cox LS; Nollen NL; Mayo MS; Faseru B; Greiner A; Ellerbeck EF; Krebill R; Tyndale RF; Benowitz NL; Ahluwalia JS
JAMA; 2022 Jun; 327(22):2201-2209. PubMed ID: 35699705
[TBL] [Abstract][Full Text] [Related]
7. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
8. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
9. Varenicline versus placebo for waterpipe smoking cessation: a double-blind randomized controlled trial.
Dogar O; Zahid R; Mansoor S; Kanaan M; Ahluwalia JS; Jawad M; Siddiqi K
Addiction; 2018 Dec; 113(12):2290-2299. PubMed ID: 30187978
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence.
Schnoll R; Leone F; Veluz-Wilkins A; Miele A; Hole A; Jao NC; Paul Wileyto E; Carroll AJ; Kalhan R; Patel J; Langer C; Lubitz SF; Hitsman B
Psychooncology; 2019 Mar; 28(3):561-569. PubMed ID: 30680852
[TBL] [Abstract][Full Text] [Related]
11. Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study.
Jiménez-Ruiz CA; Garcia Rueda M; Martinez Muñiz MA; Sellarés J; Jiménez-Fuentes MA; Lázaro Asegurado L; Rodríguez Gonzalez E; Rodriguez Garcia C; Armengol O; Abad E; Peña T; Domenech Del Rio A; Riesco Miranda JA
Monaldi Arch Chest Dis; 2017 Dec; 87(3):874. PubMed ID: 29424192
[TBL] [Abstract][Full Text] [Related]
12. Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: the ECSMOKE trial protocol.
Berlin I; Dautzenberg B; Lehmann B; Palmyre J; Liégey E; De Rycke Y; Tubach F
BMJ Open; 2019 May; 9(5):e028832. PubMed ID: 31129603
[TBL] [Abstract][Full Text] [Related]
13. Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome.
Eisenberg MJ; Windle SB; Roy N; Old W; Grondin FR; Bata I; Iskander A; Lauzon C; Srivastava N; Clarke A; Cassavar D; Dion D; Haught H; Mehta SR; Baril JF; Lambert C; Madan M; Abramson BL; Dehghani P;
Circulation; 2016 Jan; 133(1):21-30. PubMed ID: 26553744
[TBL] [Abstract][Full Text] [Related]
14. A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol.
Russo C; Caponnetto P; Cibella F; Maglia M; Alamo A; Campagna D; Frittitta L; Di Mauro M; Leotta C; Mondati E; Krysiński A; Franek E; Polosa R
Intern Emerg Med; 2021 Oct; 16(7):1823-1839. PubMed ID: 33735416
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
[TBL] [Abstract][Full Text] [Related]
16. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.
Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C
Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of varenicline and counselling for smoking cessation in an observational cohort study in China.
Jiang B; He Y; Zuo F; Wu L; Liu QH; Zhang L; Zhou CX; Cheng KK; Chan SS; Lam TH
BMJ Open; 2016 Jan; 6(1):e009381. PubMed ID: 26739730
[TBL] [Abstract][Full Text] [Related]
18. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial.
Courtney RJ; McRobbie H; Tutka P; Weaver NA; Petrie D; Mendelsohn CP; Shakeshaft A; Talukder S; Macdonald C; Thomas D; Kwan BCH; Walker N; Gartner C; Mattick RP; Paul C; Ferguson SG; Zwar NA; Richmond RL; Doran CM; Boland VC; Hall W; West R; Farrell M
JAMA; 2021 Jul; 326(1):56-64. PubMed ID: 34228066
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of varenicline alone versus in combination with nicotine lozenges for smoking cessation among hospitalised smokers (VANISH): study protocol for a randomised, placebo-controlled trial.
Gobarani RK; Abramson MJ; Bonevski B; Weeks GR; Dooley MJ; Smith BJ; Veale A; Webb A; Kirsa S; Thomas D; Miller A; Gasser R; Paul E; Parkinson J; Meanger D; Coward L; Kopsaftis Z; Rofe O; Lee P; George J
BMJ Open; 2020 Oct; 10(10):e038184. PubMed ID: 33028555
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of varenicline or bupropion and its association with nicotine metabolite ratio among smokers with COPD.
Qin R; Liu Z; Cheng AQ; Zhou XM; Su Z; Cui ZY; Li JX; Wei XW; Zhao L; Chung KF; Xiao D; Wang C
Respirology; 2024 Jun; 29(6):479-488. PubMed ID: 38494828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
